Opinions
Peter Hodson
CryoCath Technologies
CYT-T
BUY
Sep 24, 2004
Well managed and well financed. Takeover is a possibility.
$6.660
Stock price when the opinion was issued
misc industrial products
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
DON'T BUY
Just did a financing and the stock can't seem to get beyond the financing price. Unfortunately had to raise cash to get to the next level. Likes the product and the management team. Longer term, it's a good keeper, but doesn't expect a whole lot in the short term. Their US revenues have to ramp up before the market gets excited. Selling his position.
misc industrial products
HOLD
As a medical device company its got its risks. The market they are in is not fully developed, so they need to clear the FDA hurdles, develop a market and hit their milestones. Arctic Circler(R) should be a very big piece of that. Expects to have some very good news in 05/06 on this.
misc industrial products
TOP PICK
Treats atrial fibrillation (irregular heartbeat). This is a large coming market in cardiac area that is unsolved. The clinical trials they are doing in the US and Europe are indicating that the doctors are really adopting the product. Will probably be the leading therapy in this area. Expecting a takeout, especially if they get FDA approval.
misc industrial products